Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTHQZV7)

DTT Name	Mothers against decapentaplegic homolog 3 (SMAD3) DTT Info
Gene Name	SMAD3

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Approved Drug(s)

Preclinical Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

1 Approved Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
FLUORESCEIN	DMQTFAO	Ocular disease	1F00.1Z	Approved	[1]
------------------------------------------------------------------------------------

1 Preclinical Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
SIS-3	DMWBCTA	Renal fibrosis	GC01	Preclinical	[2]
------------------------------------------------------------------------------------

2 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ELLAGIC ACID	DMX8BS5	Discovery agent	N.A.	Investigative	[1]
GNF-PF-2272	DMONK0F	Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2). Bioorg Med Chem Lett. 2010 Dec 15;20(24):7331-6.
2	Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Mol Pharmacol. 2006 Feb;69(2):597-607.